EGFR and non-small cell lung carcinoma: In this setting, if there are two different NSCLC patients with ambulatory status and serum albumin falling into the same category, decisions for two patients would be the same according to the NESMS, even if the two have significantly different biological profiles (e.g., synchronous metastasis with a positive EGFR mutation versus metachronous metastasis without EGFR mutation).